Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies

BACKGROUND: Some chronic hepatitis C virus (HCV), genotype 1 infected patients treated with direct antiviral agents (DAAs) remain viremic at end of treatment (EOT+), yet go on to achieve sustained virological response 12 weeks after completion of therapy (SVR(12)). The incidence of EOT+/SVR in patie...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Therap Adv Gastroenterol
Huvudupphovsmän: Malespin, Miguel, Benyashvili, Tamara, Uprichard, Susan L., Perelson, Alan S., Dahari, Harel, Cotler, Scott J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2016
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330612/
https://ncbi.nlm.nih.gov/pubmed/28286560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16672392
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk